What even is a ‘targeted therapy’ anyway?
Targeted treatments that use drugs to stop cancer cells from growing and spreading. Find out what they are, how they work, and why they are so important...
First of its kind childhood cancer research launches, thanks to CCLG Special Named Funds and Alice’s Arc
Children’s Cancer and Leukaemia Group (CCLG) and Alice’s Arc are proud to announce a new research project that will help support families and clinicians with treatment decisions for relapsed and refractory rhabdomyosarcoma.
How do you test medicines for brain tumours?
Experts from the University of Nottingham have developed a new way of tracking how medicines move in the brain. Find out how this could help get medicines into clinical trials faster...
Can you change the future? We think so.
Research is really about helping patients, families, friends - you. So, in celebration of our first ever research blog post, we will look at how you can impact research.
CCLG partners with NCRI to further childhood cancer research
Children’s Cancer and Leukaemia Group (CCLG) is proud to have become a partner of the National Cancer Research Institute (NCRI).
Family’s fundraising in memory of Ruby funds vital blood cancer research
A pioneering research project funded by a Children’s Cancer and Leukaemia Group (CCLG) Special Named Fund is investigating how the wrong genes are being instructed in patients with T-cell leukaemia in the hope that the knowledge gleaned will inform treatments to stop cancer cells surviving.
CCLG releases impact report on its research into improving children’s cancer survival
Children’s Cancer and Leukaemia Group (CCLG) has published its first ever report showcasing the impact our research has had on driving forward pioneering breakthroughs into finding a cure for childhood cancer.
Experts publish protocol to help speed up cancer diagnosis in children
Experts from the University of Nottingham have developed a protocol for clinicians around the world which will help to close the gap between diagnosis and treatment of childhood cancer, and could increase the chance of survival from the disease.
TYAC launches first research strategy to increase funding of teenage and young adult cancer research
In TYAC's ambitious strategy for 2020 - 2025, one of our aims was to lead and fund world-class research dedicated to teenage and young adult cancers. Following a hiatus due to the COVID-19 pandemic, today we're proud to launch our first research strategy to help fulfil that goal.